ym 16151-1 has been researched along with nicardipine in 1 studies
| Studies (ym 16151-1) | Trials (ym 16151-1) | Recent Studies (post-2010) (ym 16151-1) | Studies (nicardipine) | Trials (nicardipine) | Recent Studies (post-2010) (nicardipine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 2,646 | 444 | 312 |
| Protein | Taxonomy | ym 16151-1 (IC50) | nicardipine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.314 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.2992 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1.69 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2.5 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 1.69 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 4.925 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdeaux, A; Drieu la Rochelle, C; Giudicelli, JF; Richard, V | 1 |
1 other study(ies) available for ym 16151-1 and nicardipine
| Article | Year |
|---|---|
Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; Hemodynamics; Nicardipine; Nitrophenols; Running | 1991 |